Genex Pharmaceutical, Inc. (GENX)

Market Cap	3.57K +99.9%
Revenue (ttm)	3.24M +32.8%
Net Income	342.55K -44.7%
EPS	0.02 -44.7%
Shares Out	17.85M
PE Ratio	0.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200,000
Open	0.0002
Previous Close	n/a
Day's Range	0.0002 - 0.0002
52-Week Range	0.0001 - 0.0002
Beta	-52.29
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Genex Pharmaceutical

Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People’s Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin, the People’s Republic of China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 86
• Stock Exchange: OTCMKTS
• Ticker Symbol: GENX

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 30, 2026

Data Sources Report a data error